Weisheng & Nandani Medical Laboratories collaborate to advance intelligent pharma quality in India: Our Bureau, Mumbai ...

The Central government has said that it has conducted screening of a total of six crore individuals for sickle cell disease (SCD) against the targeted seven crore under the National Sickle Cell ...

WuXi Biologics secures US FDA Pre-License Inspection approval for five facilities, first for commercial PFS line: Wuxi, China Wednesday, July 23, 2025, 13:00 Hrs [IST] WuXi Biolog ...

Centre expects to exceed target sales under PLI scheme for pharma in fourth year: Our Bureau, New Delhi Wednesday, July 23, 2025, 12:20 Hrs [IST] The Central government is expecti ...

Sarepta Therapeutics announces voluntary pause all shipments of Elevidys for Duchenne muscular dystrophy in US: Cambridge, Massachusetts Wednesday, July 23, 2025, 12:00 Hrs [IST] ...

Centre approved 48 projects under PLI Scheme for bulk drugs, says Minister: Our Bureau, New Delhi Wednesday, July 23, 2025, 12:45 Hrs [IST] The Central government has said that it ...

CCRYN and NIMHANS ink MoU to advance mind body medicine research: Our Bureau, Bengaluru Tuesday, July 22, 2025, 17:15 Hrs ...

NIMHANS & University of Oslo unveil ‘PrecInNor’ an Indo-Norwegian initiative in precision psychiatry: Our Bureau, Bengaluru ...

Copenhagen, Denmark Wednesday, July 23, 2025, 10:00 Hrs [IST] ...

AstraZeneca to invest $50 billion in America for medicines manufacturing and R&D: Cambridge, UK Wednesday, July 23, 2025, 09:00 Hrs [IST] AstraZeneca announces $50 billion of inve ...

MDC rejects Sun Pharma's application seeking separate ceiling price for antibiotic oral suspension: Gireesh Babu, New Delhi Wednesday, July 23, 2025, 08:00 Hrs [IST] The Multidisc ...

This MoU will establish a framework for the recognition of the IP as a pharmacopoeia standard for assessing applications for market authorisation for medicinal products manufactured in India. Thus, it ...